Adit Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.93 M
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 3.35%
- Profit Growth -16.32%
- Ebitda -24.89%
- Net Worth -4.29%
- Total Assets -3.03%
About Adit Pharma
Adit Pharma Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 March 1991 and has a history of 33 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.93 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Gupta, Renu Gupta, and Amit Gupta serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH1991PTC060785
-
Company No.
060785
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Mar 1991
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Adit Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gupta
|
Director | 15-Mar-1991 | Current |
|
Renu Gupta
|
Director | 15-Mar-1991 | Current |
|
Amit Gupta
|
Director | 01-Jan-2020 | Current |
Financial Performance of Adit Pharma.
Adit Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.35% increase. The company also saw a substantial fall in profitability, with a 16.32% decrease in profit. The company's net worth dipped by a decrease of 4.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adit Pharma?
In 2023, Adit Pharma had a promoter holding of 58.06% and a public holding of 41.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Zen Pharma Private LimitedAnil Gupta and Amit Gupta are mutual person
-
Sng Pharmaceuticals Private LimitedAnil Gupta and Amit Gupta are mutual person
-
Gujarat Ampoules And Vials Pvt Ltd
Anil Gupta and Amit Gupta are mutual person
-
Adit Containers Private Limited
Anil Gupta, Renu Gupta and 1 more are mutual person
-
Adit Leasing And Finance Pvt Ltd
Anil Gupta, Renu Gupta and 1 more are mutual person
-
Ha Pharma Private Limited
Anil Gupta, Renu Gupta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adit Pharma?
Adit Pharma has a workforce of 23 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adit Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adit Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.